240 related articles for article (PubMed ID: 33900681)
1. Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features.
Nichols MM; Reynolds JP; McKenney JK; Nicolas MM; McIntire PJ; Policarpio-Nicolas MLC
Cancer Cytopathol; 2021 Oct; 129(10):798-804. PubMed ID: 33900681
[TBL] [Abstract][Full Text] [Related]
2. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
[TBL] [Abstract][Full Text] [Related]
3. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
4. Applicability of the Paris System for veterans: high rates of undiagnosed low-grade urothelial neoplasia.
Chandler JB; Colunga M; Celli R; Lithgow MY; Baldassarri RJ
J Am Soc Cytopathol; 2021; 10(4):357-365. PubMed ID: 33849782
[TBL] [Abstract][Full Text] [Related]
5. Effect of the Paris system for reporting urinary cytology with histologic follow-up.
Rohra P; Ocampo Gonzalez FA; Yan L; Mir F; Furlan K; Basu S; Barua A; Cheng L; Park JW
Diagn Cytopathol; 2021 Jun; 49(6):691-699. PubMed ID: 33600080
[TBL] [Abstract][Full Text] [Related]
6. Reclassification of urinary cytology regarding The Paris System for Reporting Urinary Cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma.
Anbardar MH; Monjazeb R
Diagn Cytopathol; 2020 May; 48(5):446-452. PubMed ID: 31976626
[TBL] [Abstract][Full Text] [Related]
7. Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas.
McIntire PJ; Snow JT; Robinson BD; Rao RA; Goyal A; Heymann JJ; Siddiqui MT
Cancer Cytopathol; 2018 Jul; 126(7):498-504. PubMed ID: 29927548
[TBL] [Abstract][Full Text] [Related]
8. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology.
Cowan ML; Rosenthal DL; VandenBussche CJ
Cancer Cytopathol; 2017 Jun; 125(6):427-434. PubMed ID: 28272842
[TBL] [Abstract][Full Text] [Related]
9. Application of The Paris System in neobladder washing cytology: Comparison between the original diagnosis and correlation with histopathology.
Kim JM; Lee J; Sung SH
Diagn Cytopathol; 2023 Dec; 51(12):744-750. PubMed ID: 37610033
[TBL] [Abstract][Full Text] [Related]
10. Cyto-histo correlation and false-negative urine: Before and after the Paris system for reporting urinary cytology.
Yuan L; Gero M; Zia S; Aryal SC; Shetty S; Reynolds JP
Diagn Cytopathol; 2022 Aug; 50(8):404-410. PubMed ID: 35652594
[TBL] [Abstract][Full Text] [Related]
11. The Paris System for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma.
Yamasaki M; Taoka R; Katakura K; Matsunaga T; Kani N; Honda T; Harada S; Tohi Y; Matsuoka Y; Kato T; Okazoe H; Tsunemori H; Ueda N; Haba R; Sugimoto M
BMC Urol; 2022 Apr; 22(1):51. PubMed ID: 35382830
[TBL] [Abstract][Full Text] [Related]
12. Applying the Paris system for reporting urine cytology to challenging cytology cases.
Glass R; Rosca O; Raab S; Szabelska J; Chau K; Sheikh-Fayyaz S; Cocker R
Diagn Cytopathol; 2019 Jul; 47(7):675-681. PubMed ID: 31017746
[TBL] [Abstract][Full Text] [Related]
13. Large-scale longitudinal comparison of urine cytological classification systems reveals potential early adoption of The Paris System criteria.
Levy JJ; Liu X; Marotti JD; Kerr DA; Gutmann EJ; Glass RE; Dodge CP; Vaickus LJ
J Am Soc Cytopathol; 2022; 11(6):394-402. PubMed ID: 36068164
[TBL] [Abstract][Full Text] [Related]
14. Urine Cytology Findings in Cases of Pseudocarcinomatous Urothelial Hyperplasia of the Bladder Often Represent a Diagnostic Challenge.
Velez Torres JM; Gonzalez ML; Duarte EM; Zein-Sabatto B; Aron M; Gupta NS; Kerr DA; Netto GJ; Jorda M; Kryvenko ON
Arch Pathol Lab Med; 2023 Jun; 147(6):716-721. PubMed ID: 36191340
[TBL] [Abstract][Full Text] [Related]
15. Atypical urothelial cells classified according to the Paris System for Reporting Urinary Cytology: A 2-year experience with histological correlation from a Finnish tertiary care center-low rate and high risk of malignancy.
Pöyry E; Nykänen V; Pulkkinen J; Viljanen E; Laurila M; Kholová I
Cancer Cytopathol; 2023 Sep; 131(9):574-580. PubMed ID: 37246298
[TBL] [Abstract][Full Text] [Related]
16. The utility of upper urinary tract urine cytology before and after application of the Paris system.
Simon CT; Skala SL; Magers MJ; Weizer A; Kaffenberger SD; Chinnaiyan AM; Spratt DE; Montgomery J; Mehra R; Lew M
Diagn Cytopathol; 2019 May; 47(5):421-427. PubMed ID: 30569543
[TBL] [Abstract][Full Text] [Related]
17. Modification of The Paris System for urinary tract washing specimens using diagnostic cytological features.
Suh J; Go H; Sung C; Baek S; Hwang H; Jeong S; Cho Y
Cytopathology; 2017 Dec; 28(6):516-523. PubMed ID: 28816366
[TBL] [Abstract][Full Text] [Related]
18. Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
Celik B; Kavas G
Acta Cytol; 2023; 67(4):425-433. PubMed ID: 36731438
[TBL] [Abstract][Full Text] [Related]
19. Are we on track for diagnosing high-grade urothelial carcinoma with a minimum quantity of five malignant cells in lower tract specimens? Critical analysis of The Paris System Quantitation Criteria.
Folarin OS; Siddiqui MT
Cancer Cytopathol; 2023 Nov; 131(11):708-715. PubMed ID: 37572083
[TBL] [Abstract][Full Text] [Related]
20. Application of the Paris Reporting System for Urine Cytology: The Three-Year Experience of a Single Tertiary Care Institute in Thailand.
Phruttinarakorn B; Plumworasawat S; Kayankarnnavee J; Lualon J; Pongtippan A
Acta Cytol; 2022; 66(2):134-141. PubMed ID: 34999581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
